Fidelity Disruptive Medicine Fund
Not enough financial coverage to compute a composite score for FMEDX. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Company
Normally the fund invests at least 80% of assets in securities of disruptive medicine companies. Normally it invests primarily in equity securities. Companies within the disruptive medicine theme include but are not limited to those companies that, in the Adviser's opinion, are engaged in robotic surgery, gene therapy, genomics, rare diseases, medical devices and equipment, immunotherapy, technology-based health care platforms, and consumer wellness.
- IPO
- 2020
- HQ
- Boston, MA, US
Price Chart
Performance & Tape
- 52W High
- $11.60
- 52W Low
- $10.96
- 50D MA
- $11.34
- 200D MA
- $11.34
- Beta
- 0.78
- Avg Volume
- 0
Get TickerSpark's AI analysis on FMEDX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our FMEDX Coverage
We haven't published any research on FMEDX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate FMEDX Report →